Braun A, Kammerer S, Böhme E, Müller B, Roscher A A
Children's Hospital, Department of Clinical Chemistry and Biochemistry, University of Munich, Germany.
Biochem Biophys Res Commun. 1995 Jun 6;211(1):234-40. doi: 10.1006/bbrc.1995.1801.
The characterization of the genomic organization of the B2 bradykinin receptor gene enabled us to systematically search for polymorphic markers in this gene in a South German cohort (N = 179). We identified at least three polymorphic sites in each of the three exons existing: (i) in exon 1 next to the promoter region, a tandem repeat polymorphism consists of three common alleles, (ii) in exon 2 at nucleotide position 181 of the cDNA a C to T transition leads to an aminoacid substitution from arginine to cysteine in the receptor protein at position 14 (R14C), and (iii) a more complex repeat polymorphism, located in the 3' not-translated region of exon 3, comprises at least two common alleles and two rare variants. These new genetic markers provide valuable tools to elucidate a potential role of a hereditary dysfunction of the B2 bradykinin receptor gene in disorders such as hypertension or ischemic heart disease.
B2缓激肽受体基因的基因组组织特征使我们能够在一个德国南部队列(N = 179)中系统地搜索该基因中的多态性标记。我们在现有的三个外显子中的每一个中都鉴定出至少三个多态性位点:(i)在启动子区域旁边的外显子1中,一个串联重复多态性由三个常见等位基因组成;(ii)在cDNA第181位核苷酸的外显子2中,C到T的转换导致受体蛋白第14位(R14C)的氨基酸从精氨酸变为半胱氨酸;(iii)一个更复杂的重复多态性,位于外显子3的3'非翻译区,包括至少两个常见等位基因和两个罕见变体。这些新的遗传标记为阐明B2缓激肽受体基因遗传性功能障碍在高血压或缺血性心脏病等疾病中的潜在作用提供了有价值的工具。